Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
-
Aptose Reports Second Quarter 2025 Results
-
Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider
-
KinderCare Learning Companies, Inc. Shareholders Who Lost Money on Their Investment are Encouraged to Contact Johnson Fistel about the Class Action Lawsuit
-
Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results
-
Crescent Capital BDC, Inc. Reports Second Quarter 2025 Earnings Results; Declares a Third Quarter Base Dividend of $0.42 Per Share
-
Orezone Gold Reports Second Quarter 2025 Results
-
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
-
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
-
Caliber Reports Second Quarter 2025 Results
-
Dillard’s, Inc. to Report Second Quarter and Year-to-Date Results
-
Faraday Future Announces Second Quarter 2025 Earnings Release Date and Conference Call Details, Launching Countdown Campaign for its Dual-flywheel & Dual-bridge Eco Strategy Unveiling
-
Kelso Technologies Inc. Announces Director Retirement
-
Faraday Future Announces Second Quarter 2025 Earnings Release Date and Conference Call Details, Launching Countdown Campaign for its Dual-flywheel & Dual-bridge Eco Strategy Unveiling
-
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
-
KBR Awarded an Estimated $2.459 Billion Contract to Support Astronaut Health and Performance for Space Missions
-
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
-
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
-
FIGX Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 18, 2025
-
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results
-
Table Trac, Inc. Reports 2025 Second Quarter Earnings
-
Lulus Reports Second Quarter 2025 Results
-
Aterian Reports 2025 Second Quarter Financial Results and Provides Guidance for the Second Half of 2025
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2025 Operating Results Conference Call
-
Odysight.ai Reports Financial Results for The First Half of 2025 and Provides Business Update
-
Motorsport Games Reports Second Quarter 2025 Financial Results
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2025 Operating Results Conference Call
-
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
-
Wallchain Launches Free Mindshare Leaderboard for All CT accounts
-
Glass House Brands Reports Second Quarter 2025 Financial Results
-
Fossil Group, Inc. Reports Second Quarter 2025 Financial Results
-
Jasper Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Mondelēz International to Participate in Barclays Global Consumer Staples Conference on September 3, 2025
-
dLocal announces appointment of Chief Financial Officer
-
dLocal Reports 2025 Second Quarter Financial Results
-
SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Codexis Reports Second Quarter 2025 Financial Results
-
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndr
-
Noodles & Company Announces Second Quarter 2025 Financial Results
-
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Aqua Metals Advances Commercialization of AquaRefining™ Technology with Industry-Leading Lithium Quality and Strategic Progress During Second Quarter of 2025
-
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Global Crossing Airlines Reports Second Quarter 2025 Financial Results
-
Barfresh Announces Second Quarter 2025 Results
-
AirJoule Technologies Announces Second Quarter 2025 Results
-
Five Below, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date
